SRUTHA RAJKUMAR: Open Payments
NPI 1801887914 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 39 payments from 12 companies in 2025. Trend: 2023 $580 · 2024 $379 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 14 | $201 |
| ABBVIE INC. | 9 | $161 |
| Lundbeck LLC | 3 | $65 |
| Janssen Pharmaceuticals, Inc | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 2 | $51 |
| Corium, LLC | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
Products named: Auvelity, VRAYLAR, REXULTI, SPRAVATO, Azstarys, AUSTEDO XR, UZEDY, CAPLYTA.
Industry payments across WI — which companies pay providers there.
